Stay updated on Palovarotene for MO: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.

Latest updates to the Palovarotene for MO: Efficacy & Safety Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check13 days agoChange DetectedAn NIH-wide notice says federal agencies are transitioning to the term “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with both terms potentially appearing during the transition.SummaryDifference1%

- Check20 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the study page continues to show a 403 error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the expected study content. This prevents access to the trial details shown on the page.SummaryDifference19%

- Check55 days agoChange DetectedNo textual changes were captured for this page in the provided data; the current study details remain as published.SummaryDifference0.1%

Stay in the know with updates to Palovarotene for MO: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.